Global regulatory outlook for Crisprized plants.
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[S.l.] :
Academic Press,
2023.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- Global Regulatory Outlook for CRISPRized Plants
- Copyright Page
- Contents
- List of contributors
- About the editors
- Preface to the series
- Preface
- 1 Regulations of genome edited plants: notes from editors
- 1.1 Introduction
- 1.2 Genetically modified organisms versus CRISPR-edited crops
- 1.2.1 Genetic engineering
- 1.2.2 Gene editing
- 1.2.3 CRISPR: a splendid gift from nature
- 1.3 Regulation of genetically modified organisms (product based, process based, and plant novel traits)
- 1.3.1 Regulatory classification of genome-edited plants (SDN1, SDN2, and SDN3)
- 1.3.1.1 Site-directed nuclease 1 systems
- 1.3.1.2 Site-directed nuclease 2 systems
- 1.3.1.3 Site-directed nuclease 3 systems
- 1.4 Regulation and deregulation of CRISPR-edited plants
- 1.4.1 Policies and governance issues
- 1.4.1.1 Policies
- 1.4.1.2 Governance
- 1.4.2 Social and economic effects
- 1.5 Aspects of global regulation concerning CRISPR-edited plants
- 1.6 Regulatory challenges: questions need answers
- 1.7 Conclusion
- References
- 2 CRISPR/Cas systems and techniques
- 2.1 Introduction
- 2.2 Evolution of CRISPR-Cas technology
- 2.3 Action mechanism of CRISPR-Cas9
- 2.4 CRISPR-Cas systems
- 2.4.1 Cas3
- 2.4.2 Cas9
- 2.4.3 Cas10
- 2.5 Recent advances in CRISPR technology
- 2.5.1 Cytosine base editing
- 2.5.2 Adenine base editing
- 2.5.3 Prime editing
- 2.6 Important applications
- 2.6.1 Genome editing
- 2.6.2 CRISPR-based disease therapy
- 2.6.3 CRISPR-based biosensor
- 2.6.4 CRISPR/Cas system in plant improvement
- 2.7 Conclusion and outlook
- Acknowledgment
- Conflict of interest
- References
- 3 Applications of CRISPR/Cas in plants
- 3.1 Introduction
- 3.2 Mechanism of CRISPR/Cas-based genome editing
- 3.2.1 Adaptation
- 3.2.2 crRNA maturation
- 3.2.3 Interference
- 3.3 Application of CRISPR/Cas in plants
- 3.3.1 Quality and yield enhancement
- 3.3.2 Biotic resistance
- 3.3.3 Abiotic stress tolerance
- 3.4 Breeding technologies
- 3.5 CRISPR biosafety and regulatory concerns
- 3.6 Conclusions and future outlooks
- Acknowledgments
- Conflict of interest
- References
- 4 Reagents and their delivery systems in CRISPR/Cas
- 4.1 Introduction
- 4.2 Delivery via microinjection
- 4.3 Delivery via electroporation
- 4.4 Delivery via hydrodynamic injection
- 4.5 Viral delivery
- 4.6 Nonviral delivery methods
- 4.6.1 Encapsulation by lipids
- 4.6.2 Cell-penetrating peptides
- 4.6.3 Gold nanoparticles
- 4.6.4 DNA nanoclew
- 4.7 Delivery of CRISPR/Cas9 by extracellular vesicles
- 4.8 Other potential and emerging delivery methods for CRISPR/Cas
- 4.8.1 Induced transduction by osmocytosis and propanebetaine
- 4.8.2 Streptolysin O-mediated delivery
- 4.9 Future perspectives
- 4.10 Conclusions
- Acknowledgments
- References
- 5 Regulatory triggers of CRISPR-edited crops
- 5.1 Introduction